Can we safely continue to offer surgical treatments during the COVID-19 pandemic?
| Autor: | Fowler, Alex, Abbott, Tom E F, Pearse, Rupert M |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
MEDLINE Context (language use) Asymptomatic 03 medical and health sciences 0302 clinical medicine Pandemic Health care medicine Infection control Humans 030212 general & internal medicine Infection Control business.industry SARS-CoV-2 030503 health policy & services Health Policy COVID-19 United Kingdom Elective Surgical Procedures Emergency medicine Observational study Patient Safety medicine.symptom 0305 other medical science business Cohort study |
| Zdroj: | BMJ Quality & Safety |
| ISSN: | 2044-5423 |
| Popis: | The coronavirus pandemic has caused enormous disruption to routine healthcare in many countries, with large numbers of patients requiring hospital treatment for COVID-19.1 In the UK National Health Service (NHS) many routine care pathways were rapidly suspended to redeploy staff, hospital beds and equipment to handle the massive influx of patients. Surgical procedures were cancelled for all but the most urgent cases.2 In this issue of BMJ Quality and Safety , the Corona Hands Collaborative group report the results of a cohort study conducted over a 2-week period in April 2020, during the peak of the first wave of the COVID-19 pandemic in the UK.3 Data were collected for 1093 patients undergoing upper limb surgery in 74 NHS hospitals. A clinician survey captured data describing surgical cancellations, operating room capacity and infection control procedures at each hospital. The principal finding was that, in this patient population, the risk of death within 30 days after surgery was very low ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|